Abstract Details

Title Botulinum Toxin Type B (MYOBLOC) in Patients with Cervical Dystonia: An Open-Label Extension Study (AN072-402 EU/CD)

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 160

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Austen P. Moore	No disclosure on file
Eric J. Pappert, MD (Neurology Associates)	No disclosure on file
Hamza I. Maqsood, MD (Dept of Neurology)	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.

��ɫ��